Mr. Jackman is a director in the Biotechnology/Chemical Group. His practice includes counseling clients in areas such as global patent portfolio procurement and management strategies, FDA/ANDA practice, technology transfer, invalidity, noninfringement, freedom-to-operate and patentability opinions and due diligence investigations. He has also written and prosecuted patent applications domestically and internationally in areas such as immunology, genomics, molecular and cell biology, recombinant DNA technology, transgenics, bioprocessing, advanced biofuels, microbiology, therapeutic methods and food science. Mr. Jackman has further been involved in U.S. patent interference, reexamination and litigation matters as well as foreign oppositions.
Mr. Jackman is also a member of the firm's CleanTechSM Industry Group. He frequently lectures and publishes on intellectual property issues surrounding green technologies, and he is an Associate Editor for Clean Tech Law & Business, the first peer-reviewed journal devoted exclusively to the pursuit of environmentally sustainable technology.
Mr. Jackman is an active member of the MdBio Program Committee, a Division of the Tech Council of Maryland, which plans, organizes and facilitates educational seminars that provide a forum for members of the biotech and life science business community to learn and network with their peers. Mr. Jackman further serves as a member of the 2011/2012 BIO International Convention Program Committee.
During law school, Mr. Jackman served as Manuscripts Editor of the University of Baltimore Intellectual Property Law Journal and published an article on the "Adoption of a First-to-File Patent System: A Proposal" for the University of Baltimore Law Review. He received his J.D. with concentrations in both Intellectual Property Law and Business Law.
Mr. Jackman's thesis research concerned hepatitis B virus X antigen and its relation in the development of chronic liver diseases. As a graduate student, he co-authored a chapter entitled "Forensic Considerations in Environmental Pathology and Toxicology: Science, Regulation, Litigation, and a Tale of Two Toxins," in 2 FORENSIC SCIENCES 31F-1 (Cyril H. Wecht ed., 1995).
Prior to joining the firm, Mr. Jackman worked in the Office of Technology Development, National Cancer Institute, National Institutes of Health, as a Technology Transfer Fellow. He has also been an Adjunct Professor at the University of Baltimore School of Law co-teaching a course in Technology Transfer.
RSS
twitter